AR Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$909K	Hold	11,620	–	–	0.2%	78
2025 Q1	$842K	Hold	11,620	–	–	0.19%	75
2024 Q4	$860K	Hold	11,620	–	–	0.19%	75
2024 Q3	$767K	Sell	11,620 -750	-6%	-$49.5K	0.17%	78
2024 Q2	$1.14M	Hold	12,370	–	–	0.28%	66
2024 Q1	$1.18M	Hold	12,370	–	–	0.29%	65
2023 Q4	$943K	Sell	12,370 -1,000	-7%	-$76.2K	0.25%	68
2023 Q3	$926K	Hold	13,370	–	–	0.26%	66
2023 Q2	$1.26M	Hold	13,370	–	–	0.34%	58
2023 Q1	$1.11M	Hold	13,370	–	–	0.3%	63
2022 Q4	$998K	Buy	13,370 +9,550	+250%	+$713K	0.28%	61
2022 Q3	$316K	Hold	3,820	–	–	0.09%	101
2022 Q2	$363K	Hold	3,820	–	–	0.1%	100
2022 Q1	$450K	Hold	3,820	–	–	0.11%	98
2021 Q4	$495K	Sell	3,820 -200	-5%	-$25.9K	0.13%	97
2021 Q3	$455K	Hold	4,020	–	–	0.13%	98
2021 Q2	$416K	Hold	4,020	–	–	0.12%	98
2021 Q1	$336K	Hold	4,020	–	–	0.1%	105
2020 Q4	$367K	Hold	4,020	–	–	0.12%	100
2020 Q3	$321K	Hold	4,020	–	–	0.11%	100
2020 Q2	$278K	Hold	4,020	–	–	0.11%	105
2020 Q1	$253K	Hold	4,020	–	–	0.1%	105
2019 Q4	$313K	Hold	4,020	–	–	0.1%	104
2019 Q3	$295K	Hold	4,020	–	–	0.1%	104
2019 Q2	$248K	Hold	4,020	–	–	0.09%	111
2019 Q1	$256K	Hold	4,020	–	–	0.1%	110
2018 Q4	$205K	Hold	4,020	–	–	0.09%	110
2018 Q3	$233K	Buy	+4,020	New	+$233K	0.09%	111
2016 Q4	–	Sell	-5,148	Closed	-$207K	–	119
2016 Q3	$207K	Buy	+5,148	New	+$207K	0.09%	118